Table 1.
Age (Years) | Volume | Vector Genomes | Injection Number | Follow-up | ||
---|---|---|---|---|---|---|
First cohort | CG01 | 28 | 330 μL | 2.01 × 1010 | 2 | 1 year |
BJ03 | 27 | 200 μL | 1.22 × 1010 | 3 | 1 year | |
MM04a | 35 | 300 μL | 1.83 × 1010 | 3 | 3 years 5 months | |
Second cohort | MR05a | 42 | 700 μL | 4.27 × 1010 | 5 | 2 years |
HM06a | 22 | 770 μL | 4.7 × 1010 | 2 | 3 years | |
HT07a | 20 | 530 μL | 3.23 × 1010 | 4 | 3 years 2 months | |
Third cohort | AM08a | 19 | 700 μL | 4.27 × 1010 | 4 | 2 years 6 months |
HM09 | 15 | 800 μL | 4.8 × 1010 | 4 | 1 year | |
LC10a | 9 | 770 μL | 4.7 × 1010 | 3 | 2 years 2 months |
Patients who underwent long-term follow-up.